MRT67307
Product | Unit size | Cat. code | Docs. | Qty. | Price | |
---|---|---|---|---|---|---|
MRT67307 Kinase inhibitor; TBK1/IKKε inhibitor - InvitroFit™ |
Show product |
10 mg 3 x 10 mg |
inh-mrt
|
|
TBK1/IKKε inhibitor
TBK1/IKKε signaling inhibition by MRT67307
MRT67307 is a potent, reversible kinase inhibitor specifically blocking the function of TBK1 (TANK-binding kinase 1) and I-kappa-B kinase (IKK) epsilon (IKKε, or IKBKE), thereby preventing the phosphorylation of IRF3 (interferon regulatory factor 3) and subsequent expression of interferon-stimulated genes (ISGs) [1]. Unlike BX795 from which it is derived, MRT67307 has no noted effect on the canonical IKKs, IKKα, or IKKβ, that are involved in the activation of NF-κB [1]. Additionally, MRT67307 is a highly potent inhibitor of ULK1, a key component of the autophagy pathway [2].
Key features:
- MRT67307 potently inhibits IRF signaling in a dose-dependent manner.
- MRT67307 does not affect NF-κB signaling.
- InvitroFit™ grade: each lot is highly pure (≥95%) and functionally tested.
References:
1. Clark, K. et al., 2011. Novel cross-talk within the IKK family controls innate immunity. Biochem J 434, 93-104.
2. Petherick, K.J. et al., 2015. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem 290, 11376-11383.
Specifications
CAS number: 1190378-57-4
Solubility: 15 mg/ml in H2O
Working concentration: 1 µM to 20 μM for cell culture assays
Formula: C26H36N6O2 . x HCl
Molecular weight: 464.60 g/mol
Quality control:
- Purity: ≥95% (UHPLC)
- Inhibition of TBK1/IKKε by MRT67307 has been confirmed using cellular assays.
- Absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue™ hTLR2 and HEK-Blue™ hTLR4 cells.
Contents
MRT67307 (hydrochloride) is available in two quantities:
- inh-mrt: 10 mg
- inh-mrt-3: 3 x 10 mg
MRT67307 is shipped at room temperature.
Upon receipt, store at -20 °C.
Back to the top